Skip to main content

Table 3 Change in radiotherapy treatment design

From: Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease

Radiotherapy Treatment

Number of patients

PSMA PET/CT Additional Nodes

Nodes only detected with PSMA PET/CT

All patients

Fields modified

   

Yes (n,%)

14 (30)

5 (18)

28 (29)

No (n,%)

32 (70)

23 (82)

67 (71)

Dose modified

   

Yes (n,%)

29 (63)

23 (82)

56 (59)

No (n,%)

17 (37)

5 (18)

39 (41)

Total patients

46

28

95